Minds Navigating the Diagnosis of Mild Cognitive Impairment

Description

The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.

Conditions

Cognitive Dysfunction, Mild Cognitive Impairment

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.

Minds Navigating the Diagnosis of Mild Cognitive Impairment (MiND-MCI)

Minds Navigating the Diagnosis of Mild Cognitive Impairment

Condition
Cognitive Dysfunction
Intervention / Treatment

-

Contacts and Locations

Tuscaloosa

Tuscaloosa VA Medical Center, Tuscaloosa, Alabama, United States, 35404

Salem

Salem VA Medical Center, Salem, Virginia, United States, 24153

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Veteran
  • * age 60 or older
  • * diagnosis of MCI, diagnosed at least a month or longer prior to screening
  • * diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)
  • * self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?")
  • * self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?")
  • * English speaking, and (h) ability to provide written informed consent
  • * diagnosis of dementia or a neurodegenerative disorder
  • * diagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder)
  • * acutely suicidal or homicidal
  • * actively psychotic
  • * active substance use disorder
  • * limited life expectancy due to a terminal medical condition
  • * receiving ongoing chemotherapy or radiation treatment at time of screening
  • * residing in an assisted living or residential care facility
  • * currently participating in another psychotherapy, health promotion intervention, or cognitive training program, and
  • * any significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.

Ages Eligible for Study

60 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Tuscaloosa Research & Education Advancement Corporation,

Patricia Pilkinton, MD, PRINCIPAL_INVESTIGATOR, Tuscaloosa Veterans Affairs Medical Center

Lindsay Jacobs, PhD, PRINCIPAL_INVESTIGATOR, Tuscaloosa Veterans Affairs Medical Center

Study Record Dates

2025-09-30